UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021425
Receipt number R000024004
Scientific Title Establishment of Clinical Significance using Magnetocardiography
Date of disclosure of the study information 2016/03/30
Last modified on 2022/03/17 10:53:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Establishment of Clinical Significance using Magnetocardiography

Acronym

Clinical study using Magnetocardiography

Scientific Title

Establishment of Clinical Significance using Magnetocardiography

Scientific Title:Acronym

Clinical study using Magnetocardiography

Region

Japan


Condition

Condition

heart disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine clinical utility of magnetocardiography

Basic objectives2

Others

Basic objectives -Others

clinical utility of magnetocardiography

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

evaluation of disease severity

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Organic heart disease

Key exclusion criteria

none

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Kengo
Middle name
Last name Kusano

Organization

National Cerebral and Cardiovascular Center

Division name

Cardiovascular Medicine

Zip code

564-8565

Address

6-1 Kishibeshinmachi, Suita, Osaka, Japan

TEL

+81661701070

Email

kusanokengo@hotmail.com


Public contact

Name of contact person

1st name Kengo
Middle name
Last name Kusano

Organization

National Cerebral and Cardiovascular Center

Division name

Cardiovascular Medicine

Zip code

564-8565

Address

6-1 Kishibeshinmachi, Suita, Osaka, Japan

TEL

+81661701070

Homepage URL


Email

kusanokengo@hotmail.com


Sponsor or person

Institute

National Cerebral and Cardiovascular Center

Institute

Department

Personal name



Funding Source

Organization

National Cerebral and Cardiovascular Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Cerebral and Cardiovascular Center

Address

6-1 Kishibeshinmachi, Suita, Osaka, Japan

Tel

0661701070

Email

kusanokengo@hotmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 03 Month 30 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

High-resolution magnetocardiography can predict later cardiac events in nonischemic cardiomyopathy with normal QRS duration.
Isolated late activation detected by magnetocardiography can predict future lethal arrhythmic event in pateints with arrhythmogenic right ventricular cardiomyopathy.Late potential from magnetocardiography is associated with cardiac events in patients with early repolarization syndrome.

Results date posted

2022 Year 03 Month 17 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2016 Year 03 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Major Adverse Cardiac Events


Management information

Registered date

2016 Year 03 Month 10 Day

Last modified on

2022 Year 03 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024004


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name